The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-chloro-3-isopropyl-2-methoxypyrido[2,3-g]quinoxaline ID: ALA3735060
PubChem CID: 127036307
Max Phase: Preclinical
Molecular Formula: C15H14ClN3O
Molecular Weight: 287.75
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1nc2cc3cccnc3c(Cl)c2nc1C(C)C
Standard InChI: InChI=1S/C15H14ClN3O/c1-8(2)12-15(20-3)18-10-7-9-5-4-6-17-13(9)11(16)14(10)19-12/h4-8H,1-3H3
Standard InChI Key: DDJNKVAUOCHNHG-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.5978 1.5002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8968 0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8968 -0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5978 -1.5002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2989 -0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2806 -0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2806 0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2989 0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5978 1.5002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8968 0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8968 -0.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5978 -1.5002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1950 1.5032 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.1933 2.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1950 -1.5032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1933 -2.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2352 -0.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0037 -2.7002 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
1 10 1 0
5 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
7 14 2 0
8 11 2 0
15 16 1 0
2 15 1 0
17 18 1 0
17 19 1 0
3 17 1 0
6 20 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 287.75Molecular Weight (Monoisotopic): 287.0825AlogP: 3.96#Rotatable Bonds: 2Polar Surface Area: 47.90Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.10CX LogP: 3.87CX LogD: 3.87Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.67Np Likeness Score: -0.76
References 1. Briguglio I, Loddo R, Laurini E, Fermeglia M, Piras S, Corona P, Giunchedi P, Gavini E, Sanna G, Giliberti G, Ibba C, Farci P, La Colla P, Pricl S, Carta A.. (2015) Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives., 105 [PMID:26479028 ] [10.1016/j.ejmech.2015.10.002 ] 2. Carta A, Briguglio I, Piras S, Corona P, Ibba R, Laurini E, Fermeglia M, Pricl S, Desideri N, Atzori EM, La Colla P, Collu G, Delogu I, Loddo R.. (2016) A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems., 117 [PMID:27161176 ] [10.1016/j.ejmech.2016.03.080 ]